US$ 25.65
glp 1 agonist heart disease GLP-1 Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies GLP-1 medicines may cut clot-related
Description
Jr., et al

Endocrinol Metab (Seoul) 40: 112124, 2025

Among these, triple agonists targeting GLP-1, GIP, and glucagon receptors represent a promising next step
doi: 10.1192/j.eurpsy.2023.2417 15 BusheCJSlooffCJHaddadPMKaragianisJL

The director seems to forget that state taxpayers also fund the federal government
